Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Call us to learn more, or request an appointment online.
For more than 100 years, researchers at the Massachusetts General Hospital Corrigan Minehan Heart Center have conducted groundbreaking research and clinical trials to diagnose, treat and prevent heart disease.
From pioneering technologies that monitor heart failure patients at home to discovering a master cell that has shown a promising ability to repair damaged heart tissue, Corrigan Minehan Heart Center research has led to major advances in cardiovascular medicine.
The Corrigan Minehan Heart Center conducts the full range of research—from basic investigation that improves our understanding of the causes of cardiovascular disease to translational research that brings new discoveries to the bedside for the benefit of patients.
Mass General researchers are studying the genetic basis of atrial fibrillation and defining new treatment approaches, such as catheter ablation and left atrial appendage exclusion, for this condition.
We are developing new technologies to monitor heart failure patients remotely and improve the efficiency of cardiac devices used to treat heart failure.
Learn more about the Cardiac Resynchronization Therapy Program
Understanding the genetics of heart disease means that we can identify heart disease patients earlier and help prevent this condition in their children. We are also working to prevent heart disease in women from low-income Boston neighborhoods.
Learn more about the Cardiovascular Disease Prevention Center
Learn more about the Corrigan Women’s Heart Health Program
At the Corrigan Minehan Heart Center, we are investigating new devices to treat congenital heart defects. We also helped found a worldwide registry that enables researchers to conduct long-term studies of adults who have grown up with this condition.
Learn more about the Adult Congenital Heart Disease Program
Our research focuses on preventing cardiac events in professional athletes and highly active patients, from college students to seniors.
Our studies of stem cells and genetic risk factors help us understand why people develop heart disease. We are also leading a major clinical trial to learn how type II diabetes impacts heart disease.
Mass General is one of a few select hospitals in the nation to receive a National Institutes of Health grant to study heart transplantation. Our research explores improving the success of heart transplants in patients who are at high risk of organ rejection. We are also part of a network of advanced centers for heart failure research created by the National Heart, Lung, and Blood Institute.
Learn more about the Heart Failure and Cardiac Transplant Program
Corrigan Minehan Heart Center investigators are evaluating a unique, minimally invasive procedure called transcatheter aortic valve replacement as a treatment option for patients with severe aortic valve stenosis who are not candidates for open-heart surgery.
We are discovering new ways to diagnose heart attacks within minutes, instead of hours, and are uncovering the genetic makeup of hypertrophic cardiomyopathy.
Researchers at the Corrigan Minehan Heart Center helped found an international registry of patients with thoracic aortic disease that tracks thousands of cases and guides treatment direction to physicians worldwide.
Every day, our clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and advance patient care.
Information for health care professionals about the latest cardiovascular breakthroughs, research and clinical advances from Mass General.
Exercise for adults with congenital heart disease poses many unique challenges. In this presentation from August 12, 2021, Sherrin Gallagher, ACNP, AACC, reviews the importance of exercise and current guidelines for adults with congenital heart disease.
In this presentation from July 20, 2021, Dr. Doreen DeFaria Yeh reviews the specific medical issues that develop among children and adults born with a complex congenital heart condition called tetralogy of Fallot.
Un equipo descubrió recientemente que la aplicación de la PRS puede identificar a los pacientes de riesgo que actualmente no se identifican mediante las evaluaciones clínicas estándar.
Not even a global pandemic, with all its difficult diversions and delays, could stop the nurses of Ellison 9 from staying on track with a project timeline they had set before the COVID-19 outbreak.
Follow the Dr. Paul Dudley White Charles River Bike Path from the Museum of Science to the Galen Street Bridge in Watertown for a scenic 17-mile loop along both shores of the Charles River.
The use of accelerometers enables researchers to provide the most objective evidence to date of the link between physical activity and atrial fibrillation.
Call us to learn more, or request an appointment online.
